Authors: Cockerill, S Stubberfield, C Stables, J Carter, M Guntrip, S Smith, K McKeown, S Shaw, R Topley, P Thomsen, L Affleck, K Jowett, A Hayes, D Willson, M Woollard, P Spalding, D

Citation: S. Cockerill et al., Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2, BIOORG MED, 11(11), 2001, pp. 1401-1405

Authors: Rusnak, DW Affleck, K Cockerill, SG Stubberfield, C Harris, R Page, M Smith, KJ Guntrip, SB Carter, MC Shaw, RJ Jowett, A Stables, J Topley, P Wood, ER Brignola, PS Kadwell, SH Reep, BR Mullin, RJ Alligood, KJ Keith, BR Crosby, RM Murray, DM Knight, WB Gilmer, TM Lackey, K

Citation: Dw. Rusnak et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer, CANCER RES, 61(19), 2001, pp. 7196-7203

Authors: Stables, J Mattheakis, LC Chang, R Rees, S

Citation: J. Stables et al., Recombinant aequorin as reporter of changes in intracellular calcium in mammalian cells, METH ENZYM, 327, 2000, pp. 456-471

Authors: Stables, J Scott, S Brown, S Roelant, C Burns, D Lee, MG Rees, S

Citation: J. Stables et al., Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signalling, J RECEPT SI, 19(1-4), 1999, pp. 395-410